Inspect the evidence behind this answer.

KELLY answer

The load-bearing assumptions are population transportability; effect-size shrinkage and statistical power; identical endpoints, dose, comparator, and protocol; site and clinician heterogeneity; adherence, attrition, and missing-data handling; and protection against multiplicity or selective reporting. A larger trial is more convincing only if it preserves the causal contrast while broadening the population and sites. Because no treatment, condition, endpoint, or phase is named, KELLY does not assign a treatment-specific probability. ClinicalTrials.gov and Crossref were checked for current registry and literature availability; they are not being presented as proof for an unnamed treatment.

Evidence mode

source backed demo

Uncertainty

forward claim not settled

Memory effect

none · read-only inspection